Stead, Richard B <br/><br/>
Evaluation of the safety and pharmacodynamics of Hematide, a novel erythropoietic agent, in a phase 1, double-blind, placebo-controlled, dose-escalation study in healthy volunteers.  [electronic resource] 

 -  Blood  Sep 2006 
 - 1830-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2006-04-015818  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anemia--drug therapy<br/>Antibody Formation<br/>Drug Tolerance<br/>Erythropoiesis--drug effects<br/>Hemoglobins--metabolism<br/>Humans<br/>Male<br/>Peptides--immunology<br/>Reticulocytes--drug effects<br/>Safety